Does Comorbid Anxiety or Depression Moderate Effects of Approach Bias Modification in the Treatment of Alcohol Use Disorders?

被引:20
|
作者
Salemink, Elske [1 ]
Rinck, Mike [2 ,3 ]
Becker, Eni [2 ]
Wiers, Reinout W. [4 ]
Lindenmeyer, Johannes [5 ]
机构
[1] Univ Utrecht, Dept Clin Psychol, Expt Psychopathol EPP Lab, POB 80140, NL-3508 TC Utrecht, Netherlands
[2] Radboud Univ Nijmegen, Behav Sci Inst, Dept Clin Psychol, Nijmegen, Netherlands
[3] Ruhr Univ, Dept Clin Psychol & Psychotherapy, Bochum, Germany
[4] Univ Amsterdam, Dept Psychol, Addict Dev & Psychopathol Adapt Lab, ABC & Yield Res Prior Areas, Amsterdam, Netherlands
[5] Lindow & Med Sch, Salus Clin, Brandenburg, Germany
关键词
approach bias modification; alcohol dependence; comorbid anxiety disorder; comorbid major depressive disorder; relapse prevention; IDENTIFICATION TEST AUDIT; ACTION-TENDENCIES; SUBSTANCE USE; DEPENDENCE; RELIABILITY; PREVALENCE; ADDICTION; VALIDITY;
D O I
10.1037/adb0000642
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Objective: Approach bias modification (ApBM) is a promising new add-on training intervention for patients with alcohol use disorder (AUD). Given that comorbid anxiety and major depressive disorders are very common in AUD, and that such comorbidity affects psychological treatments negatively, the primary aim of the present study was investigating whether ApBM training is moderated by anxiety/major depressive disorder comorbidity. The secondary aim was to examine whether ApBM's relapse-preventive effect can be replicated. Method: We conducted a large-scale randomized controlled trial (RCT) in a clinical sample of AUD inpatients (n = 729) with a follow-up assessment after 1 year. All patients received 12 weeks of inpatient treatment as usual (TAU). On top of that, patients were randomized to a 12-session ApBM (TAU + ApBM), and a no-training control condition (TAU-only). Treatment success was defined as either no relapse or a single lapse shorter than 3 days in duration, ended by the patient and followed by at least 4 weeks of abstinence. Failure was defined as relapse, passed away, no contact, or refusal to provide information. Results: We found that TAU + ApBM had significantly higher success rates than TAU-only at 1-year follow-up. Importantly, anxiety/depressive comorbidity moderated ApBM's effects: Adding ApBM to TAU increased success rates more for patients with a comorbid anxiety and/or depressive disorder than for patients without such comorbidity. Conclusions: Our data suggest that adding ApBM to TAU works better in patients with a comorbid anxiety and/or depressive disorder; a promising finding gave the high rates of comorbidity in clinical practice. Public Health Significance Statement This study indicates that patients with an alcohol use disorder (AUD) who received standard care plus training to avoid alcohol cues had less relapse into drinking about a year later compared to patients who only received standard care. This study indicates that among patients with an AUD, it is particularly those who have an additional anxiety or major depressive disorder, who benefit from the alcohol-avoid training.
引用
收藏
页码:547 / 554
页数:8
相关论文
共 50 条
  • [31] Fibromyalgia Comorbid with Anxiety Disorders and Depression: Combined Medical and Psychological Treatment
    Bernik, Marcio
    Sampaio, Thiago P. A.
    Gandarela, Lucas
    [J]. CURRENT PAIN AND HEADACHE REPORTS, 2013, 17 (09)
  • [32] Alcohol use disorders comorbid with anxiety, depression and drug use disorders - Findings from the Australian National Survey of Mental Health and Well Being
    Burns, L
    Teesson, M
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2002, 68 (03) : 299 - 307
  • [33] BORDERLINE PERSONALITY AND DEPRESSION DISTINGUISH ALCOHOL USE DISORDERS WITH COMORBID POLYSUBSTANCE USE DISORDERS FROM ALCOHOL USE DISORDERS WITHOUT POLYSUBSTANCE USE
    Atkinson, E.
    Fisher, L.
    Finn, P.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 42 : 174A - 174A
  • [34] Higher suicidality in patients with comorbid major depression and alcohol use disorders
    Sher, Leo
    Oquendo, Maria A.
    Stanley, Barbara H.
    Brent, David A.
    Burke, Ainsley K.
    Arendt, Mikkel
    Tin, Adrienne
    Mann, J. J.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S142 - S143
  • [35] Treatment of Comorbid Substance Use and Anxiety Disorders A Case Study
    Ries, Richard
    Wolitzky-Taylor, Kate B.
    Operskalski, Joachim T.
    Craske, Michelle G.
    Roy-Byrne, Peter
    [J]. JOURNAL OF ADDICTION MEDICINE, 2011, 5 (04) : 248 - 253
  • [36] A Network Approach to Modeling Comorbid Internalizing and Alcohol Use Disorders
    Anker, Justin J.
    Forbes, Miriam K.
    Almquist, Zack W.
    Menk, Jeremiah S.
    Thuras, Paul
    Unruh, Amanda S.
    Kushner, Matt G.
    [J]. JOURNAL OF ABNORMAL PSYCHOLOGY, 2017, 126 (03) : 325 - 339
  • [37] Long-term use of benzodiazepines in participants with comorbid anxiety and alcohol use disorders
    Mueller, TI
    Pagano, ME
    Rodriguez, BF
    Bruce, SE
    Stout, RL
    Keller, MB
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2005, 29 (08) : 1411 - 1418
  • [38] The long-term use of benzodiazapines in subjects with comorbid anxiety and alcohol use disorders
    Pagano, ME
    Mueller, TI
    Maki, KM
    Stout, RL
    Keller, MB
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2004, 28 (05) : 114A - 114A
  • [39] The Clinical and Theoretical Basis for Integrated Cognitive Behavioral Treatment of Comorbid Social Anxiety and Alcohol Use Disorders
    Stapinski, Lexine A.
    Rapee, Ronald M.
    Sannibale, Claudia
    Teesson, Maree
    Haber, Paul S.
    Baillie, Andrew J.
    [J]. COGNITIVE AND BEHAVIORAL PRACTICE, 2015, 22 (04) : 504 - 521
  • [40] Alcohol use associated with depression in treatment trial of comorbid adolescents
    Cornelius, J. R.
    Bukstein, O. G.
    Birmaher, B.
    Kelly, T. M.
    Salloum, I. M.
    Walters, M.
    Wood, D. S.
    Clark, D. B.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2006, 30 (06) : 106A - 106A